RxDoctor Payments Data

Michael Dallolio

Psychiatry · Gainesville, FLNPI 1972531226

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 129 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by Takeda Pharmaceuticals U.S.A., Inc. at 24.1% of the total. Reporting peaked in 2021 at $751 and has fallen 66.6% since, to $251 in 2022.

$1,877in general payments, 2019–2025

Across 129 payments — averaging $14.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Takeda Pharmaceuticals U.S.A., Inc.$452
  • Sunovion Pharmaceuticals Inc.$392
  • Alkermes, Inc.$314
  • Lundbeck LLC$288
  • AbbVie$110
  • Otsuka America Pharmaceutical, Inc.$72
  • plus $250 from 9 others

What the payments were for

  • Food & beverage$1,877100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,877 in reported general payments places this provider in the 70th percentile of 2,059 psychiatry providers in Florida.

See all psychiatry providers in Florida →

Other psychiatry in Gainesville

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →